Aster DM Healthcare Limited has informed the Exchange regarding a press release dated July 30, 2025, titled "Q1 FY26 performance".
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare posted strong Q1 FY26 results with revenue rising 8% year-on-year to INR 1,078 crore and operating EBITDA growing 21% to INR 215 crore, lifting margins to 20% from 17.7% a year ago. Normalised profit after tax grew 22% to INR 90 crore, supported by better operational metrics including a 14% rise in average revenue per occupied bed to INR 50,200. The company announced a INR 580 crore, 500-bed hospital in Bengaluru's Yeswanthpur area and acquired an additional 13% stake in Aster Ramesh Hospitals, raising its holding to 70.49%. On the merger front, the preferential allotment of about 3.6% stake to Blackstone and TPG is complete, CCI approval has been received, and the deal with Quality Care India is expected to close by Q4 FY26. On a combined proforma basis, Aster plus QCIL delivered INR 2,157 crore in revenue and INR 442 crore in operating EBITDA for the quarter.
This is a positive announcement for shareholders, with broad-based growth, expanding margins, and visible capacity additions that should support future earnings. Progress on the QCIL merger and new hospital investment signal continued growth momentum, though completion remains subject to NCLT approval.